Cochlear Invests in Neurostimulator Technology Start up to Treat OSA Cochlear has invested $21 million in European company Nyxoah, Cochlear chief executive Dig Howitt told... 18 April, 2019
Novel treatment for insomnia Note: the device in the image above is not likely to have been used in... 16 April, 2018